192 related articles for article (PubMed ID: 21258190)
1. [Progressive multifocal leukoencephalopathy after rituximab therapy in a patient with mantle cell lymphoma].
Ota I; Katsura Y; Yoshida C; Yoshizawa K; Ohtani H; Sata T; Komeno T
Rinsho Ketsueki; 2010 Dec; 51(12):1786-8. PubMed ID: 21258190
[TBL] [Abstract][Full Text] [Related]
2. Depletion of B lymphocytes from cerebral perivascular spaces by rituximab.
Martin Mdel P; Cravens PD; Winger R; Kieseier BC; Cepok S; Eagar TN; Zamvil SS; Weber MS; Frohman EM; Kleinschmidt-Demasters BK; Montine TJ; Hemmer B; Marra CM; Stüve O
Arch Neurol; 2009 Aug; 66(8):1016-20. PubMed ID: 19667224
[TBL] [Abstract][Full Text] [Related]
3. Rituximab-associated progressive multifocal leukoencephalopathy derived from non-Hodgkin lymphoma: neuropathological findings and results of mefloquine treatment.
Sano Y; Nakano Y; Omoto M; Takao M; Ikeda E; Oga A; Nakamichi K; Saijo M; Maoka T; Sano H; Kawai M; Kanda T
Intern Med; 2015; 54(8):965-70. PubMed ID: 25876582
[TBL] [Abstract][Full Text] [Related]
4. Progressive multifocal leukoencephalopathy following treatment with bendamustine and rituximab.
Warsch S; Hosein PJ; Morris MI; Teomete U; Benveniste R; Chapman JR; Lossos IS
Int J Hematol; 2012 Aug; 96(2):274-8. PubMed ID: 22684926
[TBL] [Abstract][Full Text] [Related]
5. Progressive Multifocal Leukoencephalopathy Following Treatment with Rituximab in an HIV-Negative Patient with Non-Hodgkin Lymphoma. A Case Report and Literature Review.
Felli V; Di Sibio A; Anselmi M; Gennarelli A; Sucapane P; Splendiani A; Catalucci A; Marini C; Gallucci M
Neuroradiol J; 2014 Dec; 27(6):657-64. PubMed ID: 25489887
[TBL] [Abstract][Full Text] [Related]
6. JC papovavirus leukoencephalopathy after first line treatment with CHOP and rituximab.
Rey J; Belmecheri N; Bouayed N; Ivanov V; Coso D; Gastaut JA; Bouabdallah R
Haematologica; 2007 Oct; 92(10):e101. PubMed ID: 18024364
[No Abstract] [Full Text] [Related]
7. [Rapid-progressive decrease of cognitive and physical functions in a B-cell non-Hodgkin's lymphoma patient treated with rituximab/bendamustine].
Küllmer A; Herrmann G; Riecken B
Dtsch Med Wochenschr; 2013 Jun; 138(25-26):1355-9. PubMed ID: 23761057
[TBL] [Abstract][Full Text] [Related]
8. [Serial spectral EEG analysis in a patient with non-Hodgkin's lymphoma complicated by leukoencephalopathy induced by high-dose methotrexate].
Fujii Y; Mizuno Y; Hongo T; Igarashi Y; Arai T; Kino I; Okamoto K
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):713-7. PubMed ID: 3355188
[TBL] [Abstract][Full Text] [Related]
9. Progressive multifocal leukoencephalopathy (PML) in a patient with lymphoma treated with rituximab: A case report and literature review.
Al-Tawfiq JA; Banda RW; Daabil RA; Dawamneh MF
J Infect Public Health; 2015; 8(5):493-7. PubMed ID: 25666327
[TBL] [Abstract][Full Text] [Related]
10. [An autopsy case of progressive multifocal leukoencephalopathy: comparison of magnetic resonance imaging findings with the pathological findings].
Iida M; Kawakami O; Ando T; Yoshida M; Hashizume Y; Hayakawa S
Brain Nerve; 2011 Sep; 63(9):1001-7. PubMed ID: 21878703
[TBL] [Abstract][Full Text] [Related]
11. Progressive multifocal leukoencephalopathy during treatment with rituximab and CHOP chemotherapy in a patient with a diffuse large B-cell lymphoma.
Sikkema T; Schuiling WJ; Hoogendoorn M
BMJ Case Rep; 2013 Jan; 2013():. PubMed ID: 23355583
[TBL] [Abstract][Full Text] [Related]
12. Inclusion of rituximab in treatment protocols for non-Hodgkin's lymphomas and risk for progressive multifocal leukoencephalopathy.
Tuccori M; Focosi D; Blandizzi C; Pelosini M; Montagnani S; Maggi F; Pistello M; Antonioli L; Fornai M; Pepe P; Rossi G; Petrini M
Oncologist; 2010; 15(11):1214-9. PubMed ID: 21041380
[TBL] [Abstract][Full Text] [Related]
13. Progressive multifocal leukoencephalopathy in an HIV-negative patient following treatment with rituximab.
Khoury S; Shapira S; Zilberman T; Mekori YA; Hershko AY
Isr Med Assoc J; 2013 Jun; 15(6):321-2. PubMed ID: 23882904
[No Abstract] [Full Text] [Related]
14. Weekly versus twice weekly bortezomib given in conjunction with rituximab, in patients with recurrent follicular lymphoma, mantle cell lymphoma and Waldenström macroglobulinaemia.
Agathocleous A; Rohatiner A; Rule S; Hunter H; Kerr JP; Neeson SM; Matthews J; Strauss S; Montoto S; Johnson P; Radford J; Lister A
Br J Haematol; 2010 Nov; 151(4):346-53. PubMed ID: 20880120
[TBL] [Abstract][Full Text] [Related]
15. [Detection of novel rearrangement of the JC virus gene in a case of progressive multifocal leukoencephalopathy with adult T-cell leukemia].
Matsuo T; Kyoraku I; Shiomi K; Sugimoto S; Zheng HY; Nakazato M
Rinsho Shinkeigaku; 2007 Jan; 47(1):27-31. PubMed ID: 17491333
[TBL] [Abstract][Full Text] [Related]
16. Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: evolving role of biologic therapies.
Molloy ES; Calabrese LH
Arthritis Rheum; 2012 Sep; 64(9):3043-51. PubMed ID: 22422012
[TBL] [Abstract][Full Text] [Related]
17. Severe anemia during rituximab maintenance therapy for follicular lymphoma.
Liapis K; Harhalakis N; Stefanou G; Apostolidis J
J Clin Oncol; 2012 Mar; 30(8):e95-6. PubMed ID: 22231048
[No Abstract] [Full Text] [Related]
18. Progressive multifocal leukoencephalopathy following rituximab treatment in a patient with rheumatoid arthritis.
Fleischmann RM
Arthritis Rheum; 2009 Nov; 60(11):3225-8. PubMed ID: 19877057
[TBL] [Abstract][Full Text] [Related]
19. Pharmacovigilance and PML in the oncology setting.
Bennett CL
Cleve Clin J Med; 2011 Nov; 78 Suppl 2():S13-7. PubMed ID: 22123927
[TBL] [Abstract][Full Text] [Related]
20. Multifocal necrotizing leukoencephalopathy: An unusual complication of acute leukemia.
Robb J; Chalmers L; Rojiani A; Chamberlain M
Arch Neurol; 2006 Jul; 63(7):1028-9. PubMed ID: 16831976
[No Abstract] [Full Text] [Related]
[Next] [New Search]
